NR20100212
About Us
Our Company
History
Our Credo
What We Do
Edwards Products
Patient Stories

Global Locations
Our Leaders
News Releases
In the News
Charitable Fund
Overview & Guidelines
Philanthropy Reports
2011 Grantees
2010 Grantees
2009 Grantees
2008 Grantees
2007 Grantees
2006 Grantees
2005 Grantees

Financial Relationships
with Physicians

Wesley von Schack Elected to Edwards Lifesciences' Board of Directors

IRVINE, CA, February 12, 2010 -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, announced today that Wesley W. von Schack has been elected to its board of directors and will also serve as a member of its Audit and Public Policy Committee. Mr. von Schack, 65, is the retired Chairman, President and Chief Executive Officer of Energy East Corporation (now Iberdrola USA, a subsidiary of Iberdrola, S.A.), a super-regional energy delivery and services company.

"We are pleased to have someone with Wes's executive leadership experience join our board of directors," said Michael A. Mussallem, Edwards' chairman and CEO. "With over three decades of business experience, including more than 20 years of CEO experience in a highly regulated industry, I'm confident Wes will be an immediate contributor to our strong and independent board."

Currently, Mr. von Schack is the Lead Director and Chairman of the Executive Committee of The Bank of New York Mellon Corporation. In addition, he is Chairman of the Board of AEGIS Insurance Services, a property and casualty mutual company, and a Director of Teledyne Technologies Incorporated.

Mr. von Schack earned his A.B. in Economics from Fordham University, an M.B.A. from St. John's University, and a Doctorate in Finance and Management from Pace University.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company's global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, Magna, PERIMOUNT, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #

Contact Information:
Media Contact: Amanda C. Fowler 949-250-5070
Investor Contact: David K. Erickson 949-250-6826

Print Friendly
 
Contact Us | Legal Terms | Privacy Policy | © 2012 Edwards Lifesciences LLC. All rights reserved.